A former molecular geneticist at Oak Ridge National Laboratory will discuss regenerative medicine and a potential treatment for severe COVID-19 disease patients and those who struggle with “long haul” symptoms.
The talk by Cymbeline “Bem” Culiatâ€”co-founder, president, and chief science officer of NellOne Therapeutics in Knoxvilleâ€”will speak virtually to Friends of ORNL at noon Tuesday, February 8.
“While at ORNL, Culiat discovered the role of the NELL1 signaling protein in fostering the growth and maturation of musculoskeletal and cardiovascular tissues in mice and other mammals, including humans,” a press release said. “Her biotech company focuses on using her discovery to advance regenerative medicine, which involves replacing, engineering, or regenerating human or animal cells, tissues, or organs to promote healing and restore normal function. In contrast, traditional medicine typically provides treatment of symptoms rather than addressing root causes.”
To view the virtual lecture, click on the talk title on the homepage of the www.fornl.org website and click on the Zoom link near the top of the page describing the lecture. Here is Culiatâ€™s summary of what she will talk about: [Read more…]